Private equity firms have long embraced buy-and-build as a core way to generate value, and for good reason: When it works, it works beautifully. But in today's economy firms must focus on organic growth and better margins.
Don't miss out on the Dry Powder podcast episode where we dive even deeper into the buy-and-build topic. Listen now.
North American deals rebounded, scale assets and IT drew interest, and more investors flocked to India.
It’s shaping up to be a surprisingly robust year for private equity deal activity in the healthcare sector.
Deals stabilize as VC and growth equity investors make a comeback and private equity continues to moderate.
You received this email because you subscribed with your email address ([email protected]). You can update your subscription preferences or unsubscribe at any time.
Privacy Policy | Terms of Use
Global headquarters: 131 Dartmouth Street, Boston, MA USA 02116
© 2024 Bain & Company
